Healthcare / Health Information ServicesCanadian Sec
$0.63
+0.01 (+1.61%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-4.4M · quality 65.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$61M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-446.7%
↓Gross Margin
86.6%
↑Debt/Equity
0.12
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-377.1%
FCF / Net income
0.42x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.7M · net income $-15.7M · FCF $-6.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.7M | $1.7M | $10990.00 | — | — |
| Net Income | $-15.7M | $-15.7M | $-7.6M | $-3.7M | $-3.8M |
| EBITDA | $-14.0M | $-14.0M | $-7.5M | $-3.6M | $-3.7M |
| EPS | -0.12 | -0.12 | -0.17 | -0.26 | -0.57 |
| Gross Margin | 86.6% | 86.6% | 100.0% | — | — |
| Operating Margin | -767.2% | -767.2% | -54790.4% | — | — |
| Net Margin | -902.1% | -902.1% | -68731.5% | — | — |
| Balance Sheet | |||||
| Debt/Equity | 0.12 | 0.12 | 0.19 | -0.79 | -0.26 |
| Current Ratio | 0.61 | 0.61 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-6.6M | $-6.6M | $-4.4M | $-740078.00 | $-1.5M |
| Returns | |||||
| ROE | -446.7% | -446.7% | -952.8% | 504.4% | 173.5% |
| Valuation | |||||
| P/B | 15.32 | 15.32 | 30.76 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 15725.5% | 15725.5% | — | — | — |
| EPS Growth | 29.4% | 29.4% | 34.6% | 54.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+61.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.17 → -0.12
Residual
+61.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.